NCT02437331

Brief Summary

The purpose of this study is to explore the experience in being with advanced Heart failure patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 7, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

October 13, 2016

Status Verified

October 1, 2016

Enrollment Period

2 years

First QC Date

April 22, 2015

Last Update Submit

October 12, 2016

Conditions

Heart Failure

Keywords

Advanced heart failurediseased experience

Outcome Measures

Primary Outcomes (1)

  • A qualitative research to decribe the experience with advanced Heart failure patients

    describe patterns of diseases traits

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks.

Study Arms (1)

advanced heart failure

the patients was diagnostic on Chronic heart failure with NYHA class 3 and 4, AHA stage D, or LVEF\<40%.

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

the study population is diagnosis of advanced heart failure with NYHA class 3 to 4.

You may qualify if:

  • the patients' conscious must be clear,
  • vital sign is stable,
  • and can communicate in Mandarin Chinese or Taiwanese.

You may not qualify if:

  • consciousness is unclear
  • and can't have effective communication to interviewer.
  • the patient reject to join this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Zhongzheng, 10002, Taiwan

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • keidei kao, master

    study

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2015

First Posted

May 7, 2015

Study Start

April 1, 2015

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

October 13, 2016

Record last verified: 2016-10

Locations

TW(1)